Accessibility Statement Skip Navigation
  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing
  • Login
  • GDPR
  • Create a Free Account
Return to PRWeb homepage
  • News
  • Resources
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
  • Business & Money
      • Auto & Transportation

      • Aerospace, Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads and Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking and Road Transportation
      • View All Auto & Transportation

      • Business Technology

      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • View All Business Technology

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Financial Services & Investing

      • Accounting News & Issues
      • Acquisitions, Mergers and Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalization
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • View All Financial Services & Investing

      • General Business

      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls and Research
      • Trade Show News
      • View All General Business

  • Science & Tech
      • Consumer Technology

      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • View All Consumer Technology

      • Energy & Natural Resources

      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil and Gas Discoveries
      • Utilities
      • Water Utilities
      • View All Energy & Natural Resources

      • Environ­ment

      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • Aerospace & Defense
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation and Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking and Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • Carriers and Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • Animals & Pets
      • Beers, Wines and Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics and Personal Care
      • Fashion
      • Food & Beverages
      • Furniture and Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewelry
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Health

      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • View All Health

      • Sports

      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • View All Sports

      • Travel

      • Amusement Parks and Tourist Attractions
      • Gambling & Casinos
      • Hotels and Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • Advocacy Group Opinion
      • Animal Welfare
      • Congressional & Presidential Campaigns
      • Corporate Social Responsibility
      • Domestic Policy
      • Economic News, Trends, Analysis
      • Education
      • Environmental
      • European Government
      • FDA Approval
      • Federal and State Legislation
      • Federal Executive Branch & Agency
      • Foreign Policy & International Affairs
      • Homeland Security
      • Labor & Union
      • Legal Issues
      • Natural Disasters
      • Not For Profit
      • Patent Law
      • Public Safety
      • Trade Policy
      • U.S. State Policy
      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • View All People & Culture

  • Hamburger menu
  • Cision PRWeb provides efficient communication tools to continuously engage with target audiences across multiple online channels
  • Create a Free Account
    • ALL CONTACT INFO
    • Contact Us


      11AM ET Sunday – 8PM ET Friday

  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • News in Focus
    • Browse All News
    • Multimedia Gallery
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR

Two Doctors Find Possible Cure for Ebola, Costing Under $10
  • USA - English


News provided by

Cher Murphy PR

Sep 14, 2015, 13:30 ET

Share this article

Share toX

Share this article

Share toX

Dr. Robert Rowen
Dr. Robert Rowen

We are so excited about this discovery and that we can help to save so many lives through the use of ozone therapy, explains Dr. Robert Rowen, a natural health expert.

Post this

New York, New York (PRWEB) September 14, 2015 -- According to the Centers for Disease Control and Prevention (CDC), there have been nearly 6,500 deaths attributed to Ebola in just Guinea and Sierra Leone, the two hardest hit countries. Still, other countries have experienced people dying from the virus previously known as Ebola hemorrhagic fever. The good news is that two doctors known for using natural and alternative therapies have published a paper pointing to the fact that they may have the cure for Ebola by using ozone therapy. It costs less than $10, making it affordable enough to save lives around the world, not only for Ebola but perhaps many other untreatable diseases.

“We are so excited about this discovery and that we can help to save so many lives through the use of ozone therapy,” explains Dr. Robert Rowen, a natural health expert. “Of course, there are people who would rather not hear this information, such as those who may be in corrupt government positions in Sierra Leone and those peddling vaccinations, but we stand behind our discovery.”

Dr. Rowen has teamed up with Dr. Howard Robins, who is the director of The Healing Center, located in New York City. Both specialize in offering ozone therapy. They have published their study, titled “Rapid Resolution of Hemorrhagic Fever (Ebola) in Sierra Leone with Ozone Therapy,” in the 2016 issue of the African Journal of Infectious Diseases.

Ebola is characterized, according to the CDC, as a disease that has such symptoms as fever, severe headache, muscle pain, weakness, fatigue, diarrhea, vomiting, abdominal pain, and unexplained bleeding or bruising. Death usually comes quickly. The report the two doctors published found that patients recovered almost instantly, suggesting ozone therapy was able to inactivate the virus as well as modulate its damaging effects. Their method was given to four patients, three of whom had confirmed cases of Ebola. Upon initiation of therapy, each of the patients made an immediate recovery.

Ozone therapy, according to research in the Journal of Natural Science, Biology, and Medicine, has proven effects, is consistent and safe, and works with minimal and preventable side effects. They report that it is used to disinfect and treat diseases. It kills bacteria outright, inactivates viruses, and improves circulation and oxygen metabolism. The therapy is used worldwide on a variety of conditions, including infected wounds, circulatory disorders, geriatric conditions, macular degeneration, viral diseases, rheumatism/arthritis, cancer, dementia and AIDS. Ozone therapy is easy to administer. But it’s not patentable, which makes it not profitable, which prevents the government or corporations from wanting to get involved or study it.

“With a cost of under $10 per person, this is a possible cure for Ebola that can easily be distributed worldwide in order to save a lot of lives,” added Dr. Howard Robins. “Rather than the very high mortality rate that is associated with Ebola, ozone therapy can help get people back on their feet and into recovery within just a couple of days.”

Dr. Rowen is a natural health expert who focuses on nutritional remedies, oxidation (including ozone therapy), and addressing the actual cause of diseases rather than chemical symptomatic treatment. He has practiced ozone therapy longer than any living doctor in North America. Dr. Robins is the director of The Healing Center, which specializes in ozone therapy. He is a leader in intravenous ozone therapy in the country and also opened the first oxygen bar in America. Both doctors were invited to Sierra Leone in October 2014, by President Dr. Ernest Bai Koroma, to train other doctors, which is when the ozone therapy discovery was made. For more information, visit their sites at: http://www.docrowen.com and http://www.ozonedoctor.net.

About Dr. Robert Rowen and Dr. Howard Robins
Dr. Robert Rowen and Dr. Howard Robins are colleagues who have teamed up to help bring ozone therapy to the forefront as a possible cure for the Ebola virus. Both doctors are experts in the field of natural health and in ozone therapy. Dr. Rowen practices in California, while Dr. Robins practices in New York City. For more information, visit their sites at: http://www.docrowen.com and http://www.ozonedoctor.net.

Sources:
Rowen et al., Afr. J. Infect. Dis. (2016) 10 (1): 49– 54 http://www.medicalozone.info/Ozone-Therapy-Cured-EBOLA.pdf

Center for Disease Control and Prevention. Ebola virus. http://www.cdc.gov/vhf/ebola/about

Journal of Natural Science, Biology, and Medicine. Ozone Therapy: A clinical review. Jan-June 2011. http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3312702/

Cher Murphy, Cher Murphy PR, http://www.chermurphypr.com, +1 (571) 263-2128, [email protected]

Modal title

Dr. Howard Robins
Dr. Howard Robins
Dr. Howard Robins

Contact PRWeb

  • 11AM ET Sunday – 8PM ET Friday
  • Contact Us

About PRWeb

  • About PRWeb
  • Partners
  • Partnership Programs
  • Editorial Guidelines
  • Resources

Why PRWeb

  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing

Accounts

  • Create a Free Account
  • Log in
  • Contact Us

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921

Contact Cision

Products

About

My Services
  • All News Releases
  • Online Member Center
  • ProfNet
Cision Distribution Helpline
888-776-0942
  • Legal
  • Site Map
  • RSS
  • Cookie Settings
Copyright © 2025 Cision US Inc.